| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 114 companies in the Pharmaceuticals industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Mar 8, 2019 | IRWD Ironwood Pharmaceuticals Inc | Currie Mark G53 | Chief Scientific Officer | Sell | 275,000 | $13.26 | $3,647,820.00 | -19.9% | |
| Mar 7, 2019 | YCBD Cbdmd, Inc. | Sumichrast Martin A.83 | Chairman Of The Board And CEO | Sell | 325,834 | $4.00 | $1,303,336.00 | -54.6% | |
| Mar 7, 2019 | ALKS Alkermes Plc. | Landine Michael J | SVP, Corp Dev., Alkermes, Inc. | Sell | 20,000 | $32.07 | $641,362.00 | -9.8% | |
| Mar 6, 2019 | LNTH Lantheus Holdings, Inc. | Orlandi Cesare | Chief Medical Officer | Sell | 4,271 | $22.77 | $97,237.86 | -5.1% | |
| Mar 6, 2019 | LNTH Lantheus Holdings, Inc. | Duffy Michael P | See Remarks | Sell | 1,789 | $22.77 | $40,733.74 | -1.1% | |
| Mar 6, 2019 | LNTH Lantheus Holdings, Inc. | Thrall James H | Director | Sell | 3,500 | $22.78 | $79,723.00 | -26.4% | |
| Mar 6, 2019 | LNTH Lantheus Holdings, Inc. | McHugh Julie53 | Director | Sell | 2,595 | $22.77 | $59,075.18 | -12.9% | |
| Mar 6, 2019 | LNTH Lantheus Holdings, Inc. | Robertson A Frederick | Director | Sell | 3,932 | $22.77 | $89,535.57 | -8.4% | |
| Mar 6, 2019 | LNTH Lantheus Holdings, Inc. | Pruden Gary J | Director | Sell | 3,192 | $22.77 | $72,672.26 | -24.1% | |
| Mar 6, 2019 | PCRX Pacira Biosciences, Inc. | Kronenfeld Mark A. | Director | Buy | 1,700 | $38.97 | $66,244.00 | +9.5% | |
| Mar 6, 2019 | AMRX Amneal Pharmaceuticals, Inc. | Terreri Peter R | Director | Sell | 23,345 | $12.39 | $289,244.55 | -48.1% | |
| Mar 5, 2019 | ALKS Alkermes Plc. | Pops Richard F57 | Director And CEO, Alkermes Plc | Sell | 50,000 | $33.63 | $1,681,740.00 | -6.5% | |
| Mar 5, 2019 | IRWD Ironwood Pharmaceuticals Inc | McHugh Julie53 | Director | Sell | 1,500 | $14.38 | $21,570.00 | -1.7% | |
| Mar 5, 2019 | IRWD Ironwood Pharmaceuticals Inc | Olanoff Lawrence S | Director | Sell | 2,000 | $14.41 | $28,820.00 | -5.1% | |
| Mar 5, 2019 | MRK Merck & Co., Inc. | Frazier Kenneth C | Chairman, President &CEO | Sell | 20,105 | $82.00 | $1,648,684.00 | -1.2% | |
| Mar 5, 2019 | LNTH Lantheus Holdings, Inc. | Heino Mary Anne50 | President &CEO | Sell | 9,294 | $23.35 | $216,994.55 | -0.7% | |
| Mar 5, 2019 | BUDZ Weed, Inc. | Breen Nicole M | Secretary And Treasurer | Sell | 17,500 | $1.10 | $19,240.00 | - | |
| Mar 4, 2019 | EBS Emergent Biosolutions Inc. | Abdun-Nabi Daniel | CEO | Sell | 14,565 | $58.11 | $846,328.46 | -9.3% | |
| Mar 4, 2019 | AMRN Amarin Corp Plc\uk | Ekman Lars73 | Director | Sell | 135,377 | $21.31 | $2,884,904.79 | -78.7% | |
| Mar 4, 2019 | AMPH Amphastar Pharmaceuticals, Inc. | Peters William J52 | CFO, SVP &Treasurer | Sell | 1,500 | $25.36 | $38,036.55 | -1.9% | |
| Mar 4, 2019 | TEVA Teva Pharmaceutical Industries Ltd | Fridriksdottir Hafrun47 | Executive VP, Global R&D | Sell | 409 | $16.88 | $6,905.27 | -2.5% | |
| Mar 4, 2019 | AMRN Amarin Corp Plc\uk | Thero John F | President And CEO | Sell | 250,000 | $21.31 | $5,327,233.76 | -5.6% | |
| Mar 4, 2019 | TEVA Teva Pharmaceutical Industries Ltd | Nazzi Gianfranco | EVP, Growth Markets Commercial | Sell | 512 | $16.88 | $8,644.81 | -6.1% | |
| Mar 4, 2019 | TEVA Teva Pharmaceutical Industries Ltd | O'Grady Brendan P. | EVP, North America Commercial | Sell | 1,166 | $16.88 | $19,685.93 | -45.6% | |
| Mar 4, 2019 | TEVA Teva Pharmaceutical Industries Ltd | McClellan Michael James | EVP, Chief Financial Officer | Sell | 363 | $16.88 | $6,128.64 | -2.9% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.